204 related articles for article (PubMed ID: 12054660)
1. Selective binding of trisamine-modified phosphorothioate antisense DNA to target mRNA improves antisense activity and reduces toxicity.
Matsukura M; Okamoto T; Miike T; Sawai H; Shinozuka K
Biochem Biophys Res Commun; 2002 May; 293(5):1341-7. PubMed ID: 12054660
[TBL] [Abstract][Full Text] [Related]
2. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
Gao WY; Han FS; Storm C; Egan W; Cheng YC
Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
[TBL] [Abstract][Full Text] [Related]
3. Antisense phosphorothioate oligonucleotides direct both site-specific and nonspecific RNAse H cleavage of in vitro synthesized p120 mRNA.
Weidner DA; Busch H
Oncol Res; 1994; 6(6):237-42. PubMed ID: 7865899
[TBL] [Abstract][Full Text] [Related]
4. Phosphorothioate oligonucleotides block reverse transcription by the Rnase H activity associated with the HIV-1 polymerase.
Hatta T; Takai K; Yokoyama S; Nakashima H; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1995 Jun; 211(3):1041-6. PubMed ID: 7541196
[TBL] [Abstract][Full Text] [Related]
5. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
Ghosh MK; Ghosh K; Cohen JS
Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
[TBL] [Abstract][Full Text] [Related]
6. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the inhibition of reverse transcription by unmodified and modified antisense oligonucleotides.
Hatta T; Kim S; Yokoyama S; Takaku H
Nucleic Acids Symp Ser; 1993; (29):67-8. PubMed ID: 7504249
[TBL] [Abstract][Full Text] [Related]
8. Enhanced RNase H activity with methylphosphonodiester/phosphodiester chimeric antisense oligodeoxynucleotides.
Giles RV; Tidd DM
Anticancer Drug Des; 1992 Feb; 7(1):37-48. PubMed ID: 1311929
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides.
Honcharenko D; Barman J; Varghese OP; Chattopadhyaya J
Biochemistry; 2007 May; 46(19):5635-46. PubMed ID: 17411072
[TBL] [Abstract][Full Text] [Related]
10. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bacterial RNase P RNA as a drug target.
Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
[TBL] [Abstract][Full Text] [Related]
12. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
[TBL] [Abstract][Full Text] [Related]
13. Analysis of RNA-protein complexes by oligonucleotide-targeted RNase H digestion.
Günzl A; Palfi Z; Bindereif A
Methods; 2002 Feb; 26(2):162-9. PubMed ID: 12054893
[TBL] [Abstract][Full Text] [Related]
14. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
15. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and physicochemical properties of phosphorodithioate DNA.
Cummins L; Graff D; Beaton G; Marshall WS; Caruthers MH
Biochemistry; 1996 Jul; 35(26):8734-41. PubMed ID: 8679636
[TBL] [Abstract][Full Text] [Related]
17. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
18. LNA-antisense rivals siRNA for gene silencing.
Jepsen JS; Wengel J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
[TBL] [Abstract][Full Text] [Related]
19. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties.
Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J
J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352
[TBL] [Abstract][Full Text] [Related]
20. Antisense recognition of the HER-2 mRNA: effects of phosphorothioate substitution and polyamines on DNA.RNA, RNA.RNA, and DNA.DNA duplex stability.
Venkiteswaran S; Vijayanathan V; Shirahata A; Thomas T; Thomas TJ
Biochemistry; 2005 Jan; 44(1):303-12. PubMed ID: 15628872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
